Delivery Order SPE2DB20D1004-SPE2DB24FF1U1
- Not listed
- This is a federal contract award to Amerisourcebergen Drug Corp, a pharmaceutical distribution company, by the Defense Logistics Agency (DLA). The contract is a Delivery Order under an Indefinite Delivery Contract (IDC) with a ceiling value of $41,063.25. The award is for the supply of GEMTESA 75 MG TABLET 90S, a pharmaceutical product, with a period of performance through March 1, 2024. The parent company, Cencora, Inc., doing business as Amerisourcebergen, holds a significant IDC with the...
- This is a federal contract award to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA) Troop Support Medical. The contract has a ceiling value of $1,015.18 and is a delivery order contract with firm fixed pricing. The contract provides for the delivery of GEMTESA 75 MG TABLET 30S, a pharmaceutical product, to support federal healthcare programs. This award is part of a larger Indefinite Delivery Contract...
- This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, is a Delivery Order valued at $8,927.00 and issued under the Defense Logistics Agency (DLA) Troop Support Medical Indefinite Delivery Contract (IDC). The contract covers the supply of the pharmaceutical product "GEMTESA 75 MG TABLET 30S" and does not have a set-aside designation, indicating open competition. Amerisourcebergen holds a significant $999,999,999 IDC with the DLA Troop Support...
- This federal contract award was made by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The $9,711.78 firm fixed-price delivery order is for the supply of the pharmaceutical product GEMTESA 75 MG TABLET 90S, with a completion date of September 19, 2023. Amerisourcebergen Drug Corp holds a significant $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as the primary vehicle...
- This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The $36,063.29 delivery order is for GEMTESA 75 MG TABLET 30S, a pharmaceutical product, and has a completion date of December 29, 2023. The award is not designated as a set-aside contract. Amerisourcebergen Drug Corp holds a significant $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves...
- Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., received a delivery order award from the Defense Logistics Agency (DLA) on January 23, 2026, for Gemtesa 75 mg tablets (90-count supply) valued at $7,458.63. The contract is structured as a firm fixed-price delivery order with an ultimate completion date of January 26, 2026, and represents a non-competitive award. Performance will be executed at the awardee's corporate office location in Conshohocken, Pennsylvania. This delivery order...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has an award value of $8,451.42 and covers the delivery of Gemtesa 75 mg tablets. The contract is a delivery order under a larger Indefinite Delivery Contract (IDC) valued at $999,999,999.00 that Amerisourcebergen's parent company, Cencora, Inc., holds with the DLA Troop Support Medical. This IDC serves...
- This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, was issued by the Defense Logistics Agency (DLA) for $5,630.33. The contract is a Delivery Order under an Indefinite Delivery Contract (IDC) valued at $999,999,999 that Amerisourcebergen holds with the DLA Troop Support Medical. This IDC serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally,...
- This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,865.50, is a Delivery Order for the supply of GEMTESA 75 MG TABLET 90S, a pharmaceutical product. The award is associated with a larger Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA Troop Support Medical, valued at $999,999,999 and running...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $9,993.36 firm fixed-price delivery order contract is for the supply of GEMTESA 75 MG TABLET 90S, a pharmaceutical product. The contract has an ultimate completion date of February 19, 2025. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical...
- SPE2DB20D1004Indefinite Delivery Contract
- SPE2DB20D1004-SPE2DB24FF1U1Delivery Order
This contract award to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., is a Delivery Order under an Indefinite Delivery Contract (IDC) with the Defense Logistics Agency (DLA) Troop Support Medical. The IDC, valued at up to $999,999,999.00, covers the delivery of a wide range of pharmaceutical products and medical supplies to support military healthcare programs globally. The specific Delivery Order awarded is for GEMTESA 75 MG TABLET 30S, a pharmaceutical product, with a ceiling value of $1,990.09 and a period of performance through January 8, 2024. This award does not have a set-aside designation, indicating open competition. Amerisourcebergen, as a major pharmaceutical distributor, plays a critical role in supplying essential medical commodities to various federal agencies, particularly the Department of Defense and Department of Veterans Affairs.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $2.0k | 1/5/24 |